Kevin W. Quinlan is CFO at ANIKA THERAPEUTICS INC (ANIK). They have made 6 open-market trades across 1 company since 2008, most recently 2013-03-27.
CIK 0001209114
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $57K since 2008, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIK | 45,486 | $910K |
Shares reported on the most recent Form 4, priced at the 2013-04-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIK | SELL | 2013-03-27 | 2013-04-02 | $11.24 | $207K | -2.0% | +1.5% | +1.5% |
| ANIK | SELL | 2013-03-21 | 2013-03-25 | $11.24 | $636K | -2.0% | +1.5% | +1.5% |
| ANIK | BUY | 2010-08-23 | 2010-08-24 | $5.00 | $20K | -2.0% | +1.5% | +1.5% |
| ANIK | BUY | 2008-11-06 | 2008-11-10 | $5.27 | $11K | -2.0% | +1.5% | +1.5% |
| ANIK | BUY | 2008-03-19 | 2008-03-19 | $8.29 | $17K | -2.0% | +1.5% | +1.5% |
| ANIK | BUY | 2008-03-10 | 2008-03-12 | $9.88 | $10K | -2.0% | +1.5% | +1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.